Literature DB >> 23571050

Preoperative irradiation for the prevention of heterotopic ossification induces local inflammation in humans.

Paula Hoff1, Anastasia Rakow, Timo Gaber, Martin Hahne, Ufuk Sentürk, Cindy Strehl, Monique Fangradt, Katharina Schmidt-Bleek, Dörte Huscher, Tobias Winkler, Dörte Matziolis, Georg Matziolis, Harun Badakhshi, Gerd-Rüdiger Burmester, Georg N Duda, Carsten Perka, Frank Buttgereit.   

Abstract

Radiation of the hip is an established method to prevent heterotopic ossification (HO) following total hip arthroplasty (THA) but the precise mechanism is unclear. As inflammatory processes are suggested to be involved in the pathogenesis of HO, we hypothesized that the preoperative irradiation impacts local immune components. Therefore, we quantified immune cell populations and cytokines in hematomas resulting from the transection of the femur in two groups of patients receiving THA: patients irradiated preoperatively (THA-X-hematoma: THA-X-H group) in the hip region (7 Gy) in order to prevent HO and patients who were not irradiated (THA-H group) but were postoperatively treated with non-steroidal anti-inflammatory drugs (NSAIDs). Radiation resulted in significantly increased frequencies of T cells, cytotoxic T cells, NKT cells and CD25+CD127- Treg cells, whereas the number of naive CD45RA-expressing cytotoxic T cells was reduced. These results indicate differential immune cell activation, corroborated by our findings of significantly higher concentrations of pro-inflammatory cytokines (e.g., IL-6, IFNγ) and chemokines (e.g., MCP-1, RANTES) in the THA-X-H group as compared to THA-H group. In contrast, the concentration of the angiogenic VEGF was significantly suppressed in the THA-X-H group. We conclude that preoperative irradiation results in significant changes in immune cell composition and cytokine secretion in THA-hematomas, establishing a specific - rather proinflammatory - milieu. This increase of inflammatory activity together with the observed suppression in VEGF secretion may contribute to the prevention of HO.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23571050     DOI: 10.1016/j.bone.2013.03.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  9 in total

Review 1.  The immunological contribution to heterotopic ossification disorders.

Authors:  Michael R Convente; Haitao Wang; Robert J Pignolo; Frederick S Kaplan; Eileen M Shore
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

Review 2.  Inflammation in Fibrodysplasia Ossificans Progressiva and Other Forms of Heterotopic Ossification.

Authors:  Koji Matsuo; Robert Dalton Chavez; Emilie Barruet; Edward C Hsiao
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

3.  Combined reflectance and Raman spectroscopy to assess degree of in vivo angiogenesis after tissue injury.

Authors:  Shailesh Agarwal; William R Lloyd; Shawn J Loder; Michael T Chung; Charles Hwang; Michael D Morris; Benjamin Levi
Journal:  J Surg Res       Date:  2016-09-19       Impact factor: 2.192

4.  Immunological characterization of the early human fracture hematoma.

Authors:  Paula Hoff; T Gaber; C Strehl; K Schmidt-Bleek; A Lang; D Huscher; G R Burmester; G Schmidmaier; C Perka; G N Duda; F Buttgereit
Journal:  Immunol Res       Date:  2016-12       Impact factor: 2.829

5.  Risk factors for the development of heterotopic ossification in seriously burned adults: A National Institute on Disability, Independent Living and Rehabilitation Research burn model system database analysis.

Authors:  Benjamin Levi; Prakash Jayakumar; Avi Giladi; Jesse B Jupiter; David C Ring; Karen Kowalske; Nicole S Gibran; David Herndon; Jeffrey C Schneider; Colleen M Ryan
Journal:  J Trauma Acute Care Surg       Date:  2015-11       Impact factor: 3.313

Review 6.  Trauma-induced heterotopic bone formation and the role of the immune system: A review.

Authors:  Casey T Kraft; Shailesh Agarwal; Kavitha Ranganathan; Victor W Wong; Shawn Loder; John Li; Matthew J Delano; Benjamin Levi
Journal:  J Trauma Acute Care Surg       Date:  2016-01       Impact factor: 3.313

7.  Lymphocytes Are Not Required for Neurogenic Heterotopic Ossification Development after Spinal Cord Injury.

Authors:  Kylie A Alexander; Hsu-Wen Tseng; Irina Kulina; Whitney Fleming; Cedryck Vaquette; François Genêt; Marc J Ruitenberg; Jean-Pierre Lévesque
Journal:  Neurotrauma Rep       Date:  2022-02-22

8.  CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal Cells.

Authors:  Timo Gaber; Kerstin Schönbeck; Holger Hoff; Cam Loan Tran; Cindy Strehl; Annemarie Lang; Sarah Ohrndorf; Moritz Pfeiffenberger; Eric Röhner; Georg Matziolis; Gerd-R Burmester; Frank Buttgereit; Paula Hoff
Journal:  Int J Mol Sci       Date:  2018-08-07       Impact factor: 5.923

9.  PDGF is a potent initiator of bone formation in a tissue engineered model of pathological ossification.

Authors:  Owen G Davies; Liam M Grover; Mark P Lewis; Yang Liu
Journal:  J Tissue Eng Regen Med       Date:  2017-03-20       Impact factor: 3.963

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.